184 related articles for article (PubMed ID: 1330419)
1. In vitro activity of CP-74667 compared with four other fluoroquinolones.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; MirĂ³ E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolones.
Johnson DM; Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):79-83. PubMed ID: 8359012
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
Barrett MS; Jones RN; Erwin ME; Johnson DM; Briggs BM
Diagn Microbiol Infect Dis; 1991; 14(5):389-401. PubMed ID: 1665774
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
Sader HS; Erwin ME; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):372-81. PubMed ID: 1327789
[TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of the new quinolone CI-960 (PD 127391) against clinical isolates at a major tertiary care center in Saudi Arabia.
Qadri SM; Abo-Askar H; Ueno Y
Chemotherapy; 1992; 38(2):92-8. PubMed ID: 1317281
[TBL] [Abstract][Full Text] [Related]
11. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Verbist L
J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
[TBL] [Abstract][Full Text] [Related]
12. Cross-resistance and cross-susceptibility between fluoroquinolone agents.
Barry AL; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1013-8. PubMed ID: 1666360
[TBL] [Abstract][Full Text] [Related]
13. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
Pong A; Thomson KS; Moland ES; Chartrand SA; Sanders CC
J Antimicrob Chemother; 1999 Nov; 44(5):621-7. PubMed ID: 10552978
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Rotstein C; Amsterdam D; Beam TR; Mandell LA; Gorzynski EA
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Floyd-Reising SA; Kelley SG; Hindler JA; Young LS
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of T-3761, a new fluoroquinolone.
Muratani T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
[TBL] [Abstract][Full Text] [Related]
17. Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Feb; 38(2):369-70. PubMed ID: 8192468
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone.
Nakamura S; Minami A; Nakata K; Kurobe N; Kouno K; Sakaguchi Y; Kashimoto S; Yoshida H; Kojima T; Ohue T
Antimicrob Agents Chemother; 1989 Aug; 33(8):1167-73. PubMed ID: 2802544
[TBL] [Abstract][Full Text] [Related]
19. In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.
Sader HS; Jones RN; Allen SD; Gerlach EH; Murray PR; Washington JA
J Chemother; 1993 Oct; 5(5):283-8. PubMed ID: 8106899
[TBL] [Abstract][Full Text] [Related]
20. Dissociated resistance among fluoroquinolones.
Thomson KS; Sanders CC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2095-100. PubMed ID: 7811025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]